地夫可特(Deflazacort)在中国上市了吗?好购买吗？

Introduction: Deflazacort is used to treat Duchenne muscular dystrophy (DMD, a progressive disease in which muscles cannot function properly) in adults and children 2 years and older. Deflazacort belongs to a class of drugs called corticosteroids, which work by reducing inflammation and changing the way the immune system works.

Is Deflazacort available in China?

As of October 24, 2024, it has not been officially launched in China, and patients cannot purchase it directly in domestic hospitals or pharmacies. Deflazacort was developed and produced by PTC Therapeutics, Inc. and was approved by the U.S. Food and Drug Administration (FDA) on February 9, 2017, becoming the first drug to treat Duchenne muscular dystrophy on the U.S. market.

Is Deflazacort easy to buy?

Although Deflazacort has not been officially approved in the Chinese market, patients can also obtain this drug through specific medical channels.

1. Hospital pharmacies: In countries where deflazacort is already on the market, such as the United States, patients can purchase it through hospital pharmacies, usually with a doctor's prescription.

2. Physical pharmacies: In countries where deflazacort is listed, some certified physical pharmacies may provide deflazacort purchase services, and patients can purchase the drug in pharmacies.

3. Medical service institutions: For drugs that have not yet been launched in China, patients can consult medical service institutions to see if they can help purchase deflazacort.

When patients choose to purchase deflazacort, they should make sure to choose formal and reliable channels, use it correctly under the guidance of a doctor, and pay attention to possible side effects and contraindications during medication.

The side effects of Deflazacort

mainly include changes in endocrine function, increased risk of immunosuppression and infection, cardiovascular changes, gastrointestinal perforation Common side effects include Cushingoid appearance, weight gain, increased appetite, upper respiratory tract infection, cough, frequent urination, hirsutism, central obesity, and nasopharyngitis.

When using deflazacort, patients should use it under the guidance of a doctor and undergo regular physical examinations to detect any potential adverse reactions in a timely manner. At the same time, you should follow the doctor's advice, take medicine on time, and do not interrupt treatment without authorization.